IU Health Methodist Hospital — Indianapolis, Indiana

Public research footprint of IU Health Methodist Hospital, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Anatomic Stage III Breast Cancer AJCC v8 · Stage II Breast Cancer · Stage IIIA Breast Cancer · Recurrent Non-Small Cell Lung Carcinoma

Recently updated registry entries

NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)
NCT01810913 — Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to… (Suspended)
NCT04387656 — NCI COVID-19 in Cancer Patients, NCCAPS Study (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at IU Health Methodist Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.